Archived

Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “false and materially misleading” adverts for its competing weight-loss and anti-diabetes treatments. The Danish pharmaceuticals heavyweight complained that the US group – which makes rival weight-loss treatments Zepboun…

Coverage from 3 publishers 3 source reports
CBSBBCGuardian
Ozempic-maker sues rival over false advertising BBC News – Business
Update summary

What changed in this update

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

Source coverage

Source reports

Business
CBS

Novo Nordisk sues Eli Lilly, accusing it of false advertising

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

Business
Guardian

Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

Ozempic-maker sues rival over false advertisingBBC News – Business
BBC

Ozempic-maker sues rival over false advertising

Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.

Discovery

See what’s emerging. See what’s changing.

Explore stories gaining momentum and continuing events with new developments.